Dr. Carmine Gentile Joins the 4th Edition of REGEMAT 3D’s Course on 3D Bioprinting & Cell Culture
Granada, Spain – May 8, 2025 – REGEMAT 3D is proud to announce that Dr. Carmine Gentile, a global reference in cardiac tissue engineering and 3D bioprinting, will join the 4th Edition of the 3D Bioprinting & Cell Culture Course, taking place from July 7–11, 2025, in Granada, Spain.
About Dr. Carmine Gentile:
▪ Current Role: Leader of the Cardiovascular Regeneration Group at the University of Technology Sydney (UTS) and the Heart Research Institute (HRI).
▪ Academic Background: PharmD and PhD in Biomedical Sciences (Cardiovascular); research experience in Italy, the USA, and Australia.
▪ Expertise: 3D bioprinting, stem cells, cardiac regeneration, and “mini-heart” disease modeling.
▪ Career Highlights: Former Visiting Fellow at Harvard Medical School; recipient of numerous fellowships and awards.
More on his work | Research overview
His talk will enrich the course by offering first-hand insights into the development of engineered cardiac tissues and the future of regenerative cardiovascular medicine.
Course Details
▪ Dates: July 7–11, 2025
▪ Location: REGEMAT 3D HQ – Granada, Spain
▪ Duration: 35 hours of hands-on training
▪ Topics: 3D bioprinting, bioinks, bioreactors, advanced cell culture, and more
Register now
Contact: info@regemat3d.com
Don’t miss this unique opportunity to learn directly from Dr. Gentile and other global leaders in the field of biofabrication.
One thought on “Dr. Carmine Gentile Joins the 4th Edition of REGEMAT 3D’s Course on 3D Bioprinting & Cell Culture”